Building the finance backbone for a fast-growing D2C healthcare brand

Building the finance backbone for a fast-growing D2C healthcare brand

Vita's Story

D2C Healthcare Brand

Anonymized

Exploring options for your firm?

The company is a fast-growing direct-to-consumer healthcare brand in Southeast Asia, seeking to strengthen its finance and investor-readiness foundation while preparing for the next phase of scale.

CHAPTER 1

Where They Were

Vita is a young, fast-growing direct-to-consumer healthcare brand. The founders built strong product and marketing muscles, but the finance backbone had not kept pace. Reports were late or incomplete, investor materials were inconsistent, and leadership did not have a single source of truth for unit economics, cash needs, or runway.

CHAPTER 2

What We Did

1. Fixing the finance foundation

We started by rebuilding the finance stack. That included a clean chart of accounts, reliable month-end routines, and a model that tied orders, returns, discounts, freight, and fulfillment costs back to product-level margins. We coached the accounting team to help them reconcile historicals, align revenue recognition with actual delivery, and created a weekly cash view that connected inventory purchases to planned campaigns. Once the numbers were consistent, the founders and existing investors could see the real performance of the business without inconsistent spreadsheets stitched together.

2. Crafting the Series A story

With trusted data in place, we shaped an investor narrative that focused on what matters in D2C health. The deck led with product-market fit, retention and reorder behavior, payback periods on paid channels, and a clear path to improving gross margin through better sourcing and fulfillment. We built a data room that matched the story, so every claim in the deck was backed by a schedule, cohort view, or contract. When a potential lead investor engaged, we managed the diligence loop. That meant answering commercial and financial questions quickly, sharing thoughtful sensitivity cases, and translating operations into the metrics investors watch, such as contribution margin after marketing and fully-loaded CAC to LTV.

3. Simplifying a complex cap table

Vita had many early supporters who held SAFEs. The cap table was messy and created friction for new capital. We recommended aggregating the smaller holders into a special purpose vehicle. That approach kept early backers included while giving the lead investor a clean, decisive ownership line. We helped the founders align terms with counsel, planned communications to the note holders, and modeled post-money ownership so everyone understood outcomes at close and in likely future rounds.

4. Planning the post-round scale-up

As the round came together, we worked with the founders on the plan to deploy capital. The roadmap covered three pillars. First, selective product expansion that builds on existing demand and improves basket size rather than chasing unrelated categories. Second, targeted vertical integration where it truly moves the needle. Third, team growth that supports scale without bloat, including finance and supply-chain hires to keep working capital tight, and performance marketing roles tied to measurable payback.

CHAPTER 3

Where They Are Now

Vita now runs on timely monthly reporting, a living model that links marketing spend to inventory and cash, and a data room that stays updated for ongoing investor conversations. The lead investor has moved forward, the cap table is streamlined through the SPV, and the company has a clear plan to expand product lines, integrate where it adds margin, and add talent where it adds speed. We continue to work alongside the founders, running regular management reviews, tracking performance against the plan, and pushing for the decisions that keep growth disciplined. The result is a brand that can scale with confidence because its product story and financial story finally match.

Client Stories

See what Alehar can do for you

Get the freedom to focus on what you do best by partnering with our corporate finance team

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
cookie consent icon